Mairesse N, Reiss N, Galand P, Kaye A M
Mol Cell Endocrinol. 1981 Oct;24(1):53-63. doi: 10.1016/0303-7207(81)90078-2.
In a previous paper, we reported that nafoxidine (UA) stimulated the synthesis of a uterine protein showing the same electrophoretic mobility as the "estrogen-induced protein" (E2-IP) first described by Notides and Gorski. In the present work, we analyzed the IP-containing electrophoretic zone by SDS polyacrylamide-gel electrophoresis, and found that estradiol-17 beta (E2) and nafoxidine stimulated the synthesis of different proteins. As expected, estradiol-17 beta stimulated the synthesis of the E2-IP of 46 000 Mr. On the other hand, UA stimulated the synthesis of 27 000 and 30 000 Mr proteins (UA-IP). These UA-IP were not precipitated by an antiserum raised against E2-IP. Therefore, UA-IP appear to be independent entities and not degradation or precursor products of E2-IP. Both UA-IP are constitutively present in the uterus and even in higher relative amounts in rat brain. The present finding, that an "anti-estrogen", such as nafoxidine, stimulates the synthesis of different proteins than estrogen, provides a new approach to the study of the molecular mechanism of estrogen action.
在先前的一篇论文中,我们报道了萘福昔定(UA)刺激子宫中一种蛋白质的合成,该蛋白质的电泳迁移率与诺蒂兹和戈尔斯基首次描述的“雌激素诱导蛋白”(E2-IP)相同。在本研究中,我们通过SDS聚丙烯酰胺凝胶电泳分析了含IP的电泳区,发现17β-雌二醇(E2)和萘福昔定刺激合成不同的蛋白质。正如预期的那样,17β-雌二醇刺激了分子量为46000的E2-IP的合成。另一方面,UA刺激了分子量为27000和30000的蛋白质(UA-IP)的合成。这些UA-IP不能被针对E2-IP产生的抗血清沉淀。因此,UA-IP似乎是独立的实体,而不是E2-IP的降解产物或前体产物。两种UA-IP在子宫中均有组成性表达,在大鼠脑中的相对含量甚至更高。目前的发现,即一种“抗雌激素”,如萘福昔定,刺激合成与雌激素不同的蛋白质,为研究雌激素作用的分子机制提供了一种新方法。